Faro AI lands $37M to streamline clinical trial operations
San Diego-based Faro AI has raised $37 million in a Series B round to expand its platform that applies artificial intelligence to accelerate clinical trial execution. The company focuses on the post-discovery phase, aiming to reduce the time and cost of patient recruitment and trial management.
Related stories
Fatal trial incidents in China cast doubt on rapid review process · Drug development
Experts question Huidagene's transparency following fatal trial incident · Drug development
OmicsBank raises $2.25M for cross-border patient data services · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Exclusive: Faro raises $37M Series B to speed up clinical trials with AI.” Browse more stories.